Mimedx

  • Home
  • AmnioFix
  • CollaFix
  • EpiFix
  • HydroFix
  • Investors
  • About Us
  • Contact Us
  • Overview
  • Technology
  • Safety
    • Donor Testing
    • QA Regulatory
  • Surgical Application
  • Patient Information
  • Reference Articles
  • Overview
  • Technology
  • Safety
    • Donor Testing
    • QA Regulatory
  • Surgical Application
  • Patient Information
  • Reference Articles
  • Overview
  • Technology
  • Vaso Shield
  • Spine Shield
  • Reference Articles
  • Overview
  • Technology
  • Applications
  • Reference Articles
  • Overview
  • History
  • Management
  • Board of Directors
  • Quotes
  • Medical Advisory Board
  • Quotes
  • Medical Advisory Board
  • Reference Articles
  • North America
  • South America
  • Europe
  • Africa
  • Middle East
  • Asia-Pacific
  • Overview
  • Stock Information
  • News Releases
  • Corporate Governance
  • SEC Filings

SEC Filings

Jan 03, 2012 8-K - Current report

Nov 23, 2011 DEF 14A - Other definitive proxy statements

Nov 14, 2011 PRE 14A - Other preliminary proxy statements

Nov 14, 2011 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 31, 2011 8-K - Current report

Aug 04, 2011 10-Q - Quarterly report [Sections 13 or 15(d)]

Jul 27, 2011 8-K - Current report

May 10, 2011 10-Q - Quarterly report [Sections 13 or 15(d)]

May 02, 2011 10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]

Apr 01, 2011 8-K/A [Amend] - Current report

MiMedx Group is committed to the professional development of new and innovative clinical and cost-effective solutions for the use of our biomaterials as implants in orthopedics and other specialty fields of medicine.

This website is not meant as a substitute for professional medical advice.
© 2012 MiMedx Group, Inc. All rights reserved. | 60 Chastain Center Blvd, Suite 60, Kennesaw, GA 30144

LinkedIn